SANUWAVE Health, Inc. amended Fourth Amendment to Note and Warrant Purchase and Security Agreement with the noteholder party thereto (the "Holder") and NH Expansion Credit Fund Holdings LP, as agent (effective 2023-06-23).
“On June 23, 2023, SANUWAVE Health, Inc., a Nevada corporation (the “Company”), entered into a Fourth Amendment to Note and Warrant Purchase and Security Agreement (the “Amendment”), which amends that certain Note and Warrant Purchase and Security Agreement, dated as of August 6, 2020 (as amended, the “NWPSA”), with the noteholder party thereto (the “Holder”) and NH Expansion Credit Fund Holdings LP, as agent (the “Agent”).”
Lisa Sundstrom changed role as Chief Talent Officer and Secretary at SANUWAVE Health, Inc..
“determined that Ms. Sundstrom no longer satisfies the definition of "officer" set forth in Rule 16a-1(f) promulgated under the Securities Exchange Act of 1934”
Kevin A. Richardson, II changed role as Chief Strategy Officer at SANUWAVE Health, Inc..
“Mr. Frank will succeed Kevin A. Richardson, II, the former Chief Executive Officer of the Company, who stepped down as Chief Executive Officer on May 23, 2023 to serve as the Company’s Chief Strategy Officer.”
Morgan Frank was appointed as interim Chief Executive Officer at SANUWAVE Health, Inc..
“Effective May 23, 2023, the Board of Directors (the “Board”) of SANUWAVE Health, Inc. (the “Company”) appointed Morgan Frank, age 51, the current Chairman of the Board, as the Company’s interim Chief Executive Officer.”
Earnings Releases
SANUWAVE Health, Inc. reported first quarter ended March 31, 2023 results: revenue $3.8 million. Guidance reaffirmed.
“SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced 1st quarter 2023 results. For the three-months ended March 31, 2023: • Revenues increased 18% to $3.8 million for Q1 2023 versus $3.2 million for the same period last year.”
Earnings Releases
SANUWAVE Health, Inc. reported the year ended December 31, 2022 results: revenue $16.7 million. Guidance initiated.
“Revenues increased by 29% to $16.7 million for the year ended December 31, 2022”
Earnings Releases
SANUWAVE Health, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $5.5 million. Guidance initiated.
“Revenues increased by 32% to $5.5 million for the fourth quarter ended December 31, 2022”
Auditor Changes
SANUWAVE Health, Inc. reported that prior financial statements should not be relied upon.
“On March 28, 2023, the Audit Committee of the Board of Directors (the "Audit Committee") of SANUWAVE Health, Inc. (the "Company") after discussion with management concluded that the interim financial statements contained in the Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022 (the "Form 10-Qs") should no longer be relied upon”
Shareholder Votes
SANUWAVE Health, Inc. shareholders approved To approve an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000 at the 2022-12-20 meeting.
“Proposal 2. To approve an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000 . Votes For Votes Against Abstain Broker Non-Votes 294,922,676 23,364,904 1,128,525 0”
Shareholder Votes
SANUWAVE Health, Inc. shareholders approved To approve an amendment to the Company's Articles of Incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from 1-for-50 to 1-for-100 at the 2022-12-20 meeting.
“Proposal 1. To approve an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the Company’s common stock, par value $0.001 (the “Common Stock”), at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by the Board of Directors. Votes For Votes Against Abstain Broker Non-Votes 306,476,740 11,981,209 958,156 0”
Earnings Releases
SANUWAVE Health, Inc. reported the quarter, starting April 1, 2022 and ending June 30, 2022 results: revenue $3.9 million.
“Revenues for the quarter, starting April 1, 2022 and ending June 30, 2022, came in at $3.9 million.”
Earnings Releases
SANUWAVE Health, Inc. reported the 3 months ended September 30, 2022 results: revenue $4.2 million.
“Revenues increased 12% to $4.2 million for the 3 months ended September 30, 2022, versus $3.7 million for the same period last year.”
Lisa E. Sundstrom was appointed as Chief Talent Officer at SANUWAVE Health, Inc..
“On August 16, 2022, in connection with Dr. Rinow’s appointment as Chief Financial Officer of the Company, Lisa E. Sundstrom transitioned out of the Chief Financial Officer role and was appointed Chief Talent Officer of the Company.”
Toni Rinow was appointed as Chief Financial Officer at SANUWAVE Health, Inc..
“On August 16, 2022, SANUWAVE Health, Inc. (the “ Company ”) appointed Dr. Toni Rinow, age 58, Chief Financial Officer and designated her the principal financial officer of the Company.”
Morgan Frank was appointed as Chair of the Board at SANUWAVE Health, Inc..
“On August 5, 2022, Morgan Frank was appointed to the Board to serve as Chair, effective immediately.”
Jim Tyler was appointed as Director at SANUWAVE Health, Inc..
“On April 10, 2022, Messrs. Jeffrey Blizard, Ian Miller and Jim Tyler were appointed to the Board, effective immediately.”
Ian Miller was appointed as Director at SANUWAVE Health, Inc..
“On April 10, 2022, Messrs. Jeffrey Blizard, Ian Miller and Jim Tyler were appointed to the Board, effective immediately.”
Jeffrey Blizard was appointed as Director at SANUWAVE Health, Inc..
“On April 10, 2022, Messrs. Jeffrey Blizard, Ian Miller and Jim Tyler were appointed to the Board, effective immediately.”
John Nemelka resigned as director at SANUWAVE Health, Inc..
“Mr. John Nemelka informed the board of directors (the “Board”) of Sanuwave Health, Inc. (the “Company”) of his resignation as a member of the Board, effective immediately.”
Tom Price resigned as Director at SANUWAVE Health, Inc..
“On September 28, 2021, Dr. Tom Price informed the board of directors (the “Board”) of Sanuwave Health, Inc. (the “Company”) of his resignation as a member of the Board, effective immediately.”
Maj-Britt Kaltoft resigned as Director at SANUWAVE Health, Inc..
“On June 27, 2021, Maj-Britt Kaltoft informed the board of directors (the “Board”) of Sanuwave Health, Inc. (the “Company”) of her resignation as a member of the Board, effective June 28, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.